SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.918
AS - Asia 5.621
EU - Europa 3.460
SA - Sud America 767
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 9
Totale 22.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.611
SG - Singapore 2.146
CN - Cina 1.487
DE - Germania 859
VN - Vietnam 598
BR - Brasile 581
UA - Ucraina 577
IT - Italia 490
GB - Regno Unito 413
HK - Hong Kong 406
TR - Turchia 367
FI - Finlandia 346
FR - Francia 207
CA - Canada 193
SE - Svezia 153
RU - Federazione Russa 146
BD - Bangladesh 145
JP - Giappone 115
IN - India 113
MX - Messico 66
AR - Argentina 57
PL - Polonia 51
ZA - Sudafrica 47
IQ - Iraq 43
BE - Belgio 42
NL - Olanda 40
ES - Italia 36
PK - Pakistan 36
LT - Lituania 30
CO - Colombia 29
EC - Ecuador 29
ID - Indonesia 29
UZ - Uzbekistan 21
VE - Venezuela 19
CL - Cile 16
MA - Marocco 16
MY - Malesia 16
AE - Emirati Arabi Uniti 15
PH - Filippine 13
SA - Arabia Saudita 13
EG - Egitto 11
PE - Perù 11
JM - Giamaica 10
PY - Paraguay 10
TN - Tunisia 10
AL - Albania 9
AU - Australia 9
UY - Uruguay 9
AT - Austria 8
CZ - Repubblica Ceca 8
BG - Bulgaria 7
IR - Iran 7
JO - Giordania 7
CR - Costa Rica 6
IL - Israele 6
KE - Kenya 6
LB - Libano 6
SN - Senegal 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
HN - Honduras 5
NP - Nepal 5
SV - El Salvador 5
CH - Svizzera 4
ET - Etiopia 4
HR - Croazia 4
PA - Panama 4
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
HU - Ungheria 3
KZ - Kazakistan 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SR - Suriname 3
AZ - Azerbaigian 2
BJ - Benin 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
GD - Grenada 2
GR - Grecia 2
IE - Irlanda 2
KH - Cambogia 2
KR - Corea 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
Totale 22.873
Salva come PNG Salva come JPEG
Città #
Ashburn 1.526
Singapore 1.420
Fairfield 1.109
Woodbridge 1.076
San Jose 716
Houston 673
Jacksonville 616
Ann Arbor 559
Chandler 519
Santa Clara 497
Beijing 488
Seattle 422
Hong Kong 402
Wilmington 392
Cambridge 352
Munich 342
Dallas 282
Los Angeles 268
New York 266
Council Bluffs 226
Ho Chi Minh City 199
Izmir 193
Nanjing 178
Helsinki 152
Milan 142
Hanoi 132
Princeton 119
San Diego 113
Tokyo 111
Boardman 100
Lauterbourg 97
Orem 87
Denver 79
Shanghai 78
Brooklyn 72
Turku 71
Montreal 63
São Paulo 63
London 60
Atlanta 58
Nanchang 58
Dearborn 57
Toronto 55
Phoenix 54
Shenyang 51
Frankfurt am Main 46
Buffalo 45
San Francisco 45
Falls Church 44
Chicago 42
Brussels 40
Warsaw 39
Boston 38
Mexico City 35
Bremen 33
Falkenstein 33
Hefei 33
Hebei 32
Tianjin 32
Ferrara 31
Johannesburg 30
Auburn Hills 29
Jiaxing 29
Changsha 28
Da Nang 27
Jinan 27
Mountain View 27
San Mateo 27
Manchester 26
Philadelphia 26
Chennai 23
Mcallen 22
Moscow 22
Norwalk 22
Stockholm 21
Haiphong 20
Redwood City 20
Rio de Janeiro 20
Addison 19
Poplar 19
Tashkent 19
The Dalles 19
Kunming 18
Zhengzhou 18
Baghdad 17
Montréal 17
Amsterdam 16
Mumbai 16
Bexley 15
Curitiba 14
Dhaka 13
Guangzhou 13
Hải Dương 13
Lahore 13
Belo Horizonte 12
Indiana 12
Ningbo 12
Tappahannock 12
Ankara 11
Calgary 11
Totale 15.936
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.251
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 399
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 341
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 324
A new selective antagonist of the nociceptin receptor 282
Effects of vasoactive agents in healthy and diseased human saphenous veins 280
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 274
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 272
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 271
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 270
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 265
A new ligand for the urotensin II receptor 260
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 246
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 245
Ala scan analogues of HOE 140. Synthesis and biological activities 242
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 240
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 237
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 236
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 231
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 230
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 228
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 228
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 228
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 225
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 223
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 222
Pharmacological characterisation of novel kinin B2 receptor ligands 221
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 220
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 218
B1 and B2 kinin receptors in various species 216
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 215
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 213
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 213
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 210
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 209
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 207
Pharmacological characterization of nociceptin receptor: an in vitro study 207
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 205
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 204
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 204
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 204
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 203
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 202
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 200
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 199
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 199
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 197
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 196
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 194
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 189
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 188
Characterization of the human vascular kinin B2 receptor by binding assays. 185
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 185
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 183
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 180
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 180
Nociceptin/orphanin FQ receptor ligands 180
Structure-activity relationship study on human urotensin II 180
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 180
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 179
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 178
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 175
ANTAGONISTI DEL RECETTORE UT E LORO USI TERAPEUTICI 174
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 173
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 173
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 172
Pharmacology of nociceptin and its receptor: a novel therapeutic target 170
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 169
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 165
Characterization of endothelin receptors in the human umbilical artery and vein 165
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 163
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 162
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 162
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 161
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT(1) and AT(2) receptors 161
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 160
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 160
Pharmacology of the Kallikrein-Kinin system 160
Receptors for kinins in the human isolated umbilical vein 156
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 156
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 155
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 152
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 148
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 147
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 147
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 143
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 143
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 138
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 137
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 135
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 134
Characterization of the human vascular kinin B2 receptor by binding assays 131
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 130
Identificazione di un antagonista del recettore UT 130
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 128
Identificazione di un agonista parziale del recettore per il neuropeptide S 128
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 124
Totale 20.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.264 0 137 96 98 87 56 73 72 57 94 123 371
2022/20231.332 125 50 62 168 224 176 112 100 196 7 68 44
2023/2024631 76 78 37 16 39 133 21 42 13 12 14 150
2024/20252.785 54 51 206 106 337 315 133 177 397 244 405 360
2025/20267.580 827 316 632 996 1.142 479 896 341 703 783 310 155
2026/20271.594 1.253 341 0 0 0 0 0 0 0 0 0 0
Totale 22.996